102
|
Techau M, Lunde A, Pedersen CG, Green A, Johannessen H, Nissen N. Non-participants and reasons for non-participation in a pragmatic trial of energy healing as cancer rehabilitation. Eur J Integr Med 2014. [DOI: 10.1016/j.eujim.2014.03.003] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
103
|
Fischer FH, Lewith G, Witt CM, Linde K, von Ammon K, Cardini F, Falkenberg T, Fønnebø V, Johannessen H, Reiter B, Uehleke B, Weidenhammer W, Brinkhaus B. High prevalence but limited evidence in complementary and alternative medicine: guidelines for future research. BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE 2014; 14:46. [PMID: 24499316 PMCID: PMC3931324 DOI: 10.1186/1472-6882-14-46] [Citation(s) in RCA: 82] [Impact Index Per Article: 8.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 08/12/2013] [Accepted: 02/04/2014] [Indexed: 01/09/2023]
Abstract
The use of complementary and alternative Medicine (CAM) has increased over the past two decades in Europe. Nonetheless, research investigating the evidence to support its use remains limited. The CAMbrella project funded by the European Commission aimed to develop a strategic research agenda starting by systematically evaluating the state of CAM in the EU. CAMbrella involved 9 work packages covering issues such as the definition of CAM; its legal status, provision and use in the EU; and a synthesis of international research perspectives. Based on the work package reports, we developed a strategic and methodologically robust research roadmap based on expert workshops, a systematic Delphi-based process and a final consensus conference. The CAMbrella project suggests six core areas for research to examine the potential contribution of CAM to the health care challenges faced by the EU. These areas include evaluating the prevalence of CAM use in Europe; the EU cititzens' needs and attitudes regarding CAM; the safety of CAM; the comparative effectiveness of CAM; the effects of meaning and context on CAM outcomes; and different models for integrating CAM into existing health care systems. CAM research should use methods generally accepted in the evaluation of health services, including comparative effectiveness studies and mixed-methods designs. A research strategy is urgently needed, ideally led by a European CAM coordinating research office dedicated to fostering systematic communication between EU governments, the public, charitable and industry funders, researchers and other stakeholders. A European Centre for CAM should also be established to monitor and further a coordinated research strategy with sufficient funds to commission and promote high quality, independent research focusing on the public's health needs and pan-European collaboration. There is a disparity between highly prevalent use of CAM in Europe and solid knowledge about it. A strategic approach on CAM research should be established to investigate the identified gaps of knowledge and to address upcoming health care challenges.
Collapse
Affiliation(s)
- Felix H Fischer
- Institute for Social Medicine, Epidemiology, and Health Economics, Charité Universitätsmedizin, Luisenstr. 57, 10098 Berlin, Germany
| | - George Lewith
- Complementary and Integrated Medicine Research Unit, University of Southampton, Southampton, UK
| | - Claudia M Witt
- Institute for Social Medicine, Epidemiology, and Health Economics, Charité Universitätsmedizin, Luisenstr. 57, 10098 Berlin, Germany
- Center for Integrative Medicine, School of Medicine, University of Maryland, Baltimore, USA
| | - Klaus Linde
- Institute of General Practice, Klinikum rechts der Isar, Technische Universität München, Munich, Germany
| | - Klaus von Ammon
- Institute of Complementary Medicine (KIKOM), University of Bern, Bern, Switzerland
| | - Francesco Cardini
- Healthcare and Social Agency of Emilia Romagna Region, Bologna, Italy
| | - Torkel Falkenberg
- Research Unit for Integrative Healthcare Research, Karolinska Institute, Stockholm, Sweden
- I C – The Integrative Care Science Center, Järna, Sweden
| | - Vinjar Fønnebø
- National Research Center on Complementary and Alternative Medicine (NAFKAM), University of Tromsø, Tromsø, Norway
| | - Helle Johannessen
- Institute of Public Health, Research Unit Health, Man and Society, University of Southern Denmark, Odense, Denmark
| | - Bettina Reiter
- International Academy for Holistic Medicine, Vienna, Austria
| | - Bernhard Uehleke
- Institute of Complementary Medicine, Department of Internal Medicine, University Hospital Zurich, Zurich, Switzerland
| | - Wolfgang Weidenhammer
- Competence Centre for Complementary Medicine and Naturopathy, Klinikum rechts der Isar, Technische Universität, Munich, Germany
| | - Benno Brinkhaus
- Institute for Social Medicine, Epidemiology, and Health Economics, Charité Universitätsmedizin, Luisenstr. 57, 10098 Berlin, Germany
| |
Collapse
|
104
|
Kennedy DA, Lupattelli A, Koren G, Nordeng H. Herbal medicine use in pregnancy: results of a multinational study. Altern Ther Health Med 2013; 13:355. [PMID: 24330413 PMCID: PMC4029224 DOI: 10.1186/1472-6882-13-355] [Citation(s) in RCA: 124] [Impact Index Per Article: 11.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/25/2013] [Accepted: 12/09/2013] [Indexed: 12/11/2022]
Abstract
BACKGROUND The use of complementary and alternative medicines (CAM) is growing in the general population. Herbal medicines are used in all countries of the world and are included in the top CAM therapies used. METHODS A multinational study on how women treat disease and pregnancy-related health ailments was conducted between October 2011 and February 2012 in Europe, North and South America and Australia. In this study, the primary aim was to determine the prevalence of herbal medicine use in pregnancy and factors related to such use across participating countries and regions. The secondary aim was to investigate who recommended the use of herbal medication in pregnancy. RESULTS There were 9,459 women from 23 countries participating in the study. Of these, 28.9% reported the use of herbal medicines in pregnancy. Most herbal medicines were used for pregnancy-related health ailments such as cold and nausea. Ginger, cranberry, valerian and raspberry were the most commonly used herbs in pregnancy. The highest reported rate of herbal use medicines was in Russia (69%). Women from Eastern Europe (51.8%) and Australia (43.8%) were twice as likely to use an herbal medicine versus other regions. Women using herbal medicines were characteristically having their first child, non-smokers, using folic acid and consuming some alcohol in pregnancy. Also, women who were currently students and women with an education other than a high school degree were more likely to use herbal medicines than other women. Although 1 out of 5 women stated that a physician had recommended the herbal use, most women used herbal medicine in pregnancy on their own initiative. CONCLUSIONS In this multinational study herbal medicine use in pregnancy was high although there were distinct differences in the herbs and users of herbal medicines across regions. Most commonly the women self-medicated with herbal medicine to treat pregnancy-related health ailments. More knowledge regarding the efficacy and safety of herbal medicines in pregnancy is warranted.
Collapse
|
105
|
Nissen N, Weidenhammer W, Schunder-Tatzber S, Johannessen H. Public health ethics for complementary and alternative medicine. Eur J Integr Med 2013. [DOI: 10.1016/j.eujim.2012.11.003] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
106
|
Weidenhammer W, Brinkhaus B. CAMbrella--a pan-European research network for complementary and alternative medicine: from the beginnings up to first results. FORSCHENDE KOMPLEMENTARMEDIZIN (2006) 2012; 19 Suppl 2:3-5. [PMID: 23883938 DOI: 10.1159/000342753] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/02/2023]
Affiliation(s)
- Wolfgang Weidenhammer
- Competence Centre for Complementary Medicine and Naturopathy, Klinikum rechts der Isar, Technical University Munich, Germany.
| | | |
Collapse
|